MARKET

PULM

PULM

Pulmatrix
NASDAQ
2.020
-0.040
-1.94%
After Hours: 2.070 +0.05 +2.48% 18:30 12/01 EST
OPEN
2.070
PREV CLOSE
2.060
HIGH
2.080
LOW
2.000
VOLUME
12.12K
TURNOVER
0
52 WEEK HIGH
4.490
52 WEEK LOW
1.640
MARKET CAP
7.38M
P/E (TTM)
-0.4535
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at PULM last week (1120-1124)?
Weekly Report · 6d ago
Weekly Report: what happened at PULM last week (1113-1117)?
Weekly Report · 11/20 09:47
Buy Rating for Pulmatrix: Potential of Ongoing Projects, Drug Formulations, and Strategic Partnerships
TipRanks · 11/13 11:28
Weekly Report: what happened at PULM last week (1106-1110)?
Weekly Report · 11/13 09:44
Pulmatrix: Current report
Press release · 11/09 15:00
Pulmatrix: Quarterly report
Press release · 11/09 15:00
Weekly Report: what happened at PULM last week (1030-1103)?
Weekly Report · 11/06 09:46
Weekly Report: what happened at PULM last week (1023-1027)?
Weekly Report · 10/30 09:52
More
About PULM
Pulmatrix, Inc. is a clinical-stage biopharmaceutical company, which is focused on developing inhaled therapies to address serious pulmonary diseases and central nervous system (CNS) disorders using its patented inhaled small particles easily respirable and emitted (iSPERSE) technology. Its inhaled therapeutic products based on its dry powder delivery technology, namely iSPERSE enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways. Its iSPERSE’s lead development program, PUR1900 is its inhaled formulation of itraconazole, an anti-fungal drug commercially available as an oral drug, which it is developing to treat and prevent pulmonary fungal infections. Its pipeline also includes PUR3100 for the treatment of acute migraine, and PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD).

Webull offers Pulmatrix Inc stock information, including NASDAQ: PULM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PULM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PULM stock methods without spending real money on the virtual paper trading platform.